Harpagophytum zeyheri
Harpagophytum zeyheri · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Harpagophytum zeyheri is a botanical species widely recognized for its significant analgesic activities. The plant's therapeutic potential is largely driven by its chemical composition, which includes key compounds such as harpagoside, 8-p-coumaroylharpagide, and various iridoids. Research has demonstrated its ability to influence biological conditions involving Fusobacterium nucleatum and the regulation of respiratory burst. These medicinal properties are frequently studied through the use of aqueous extracts derived from Harpagophyti radix. Consequently, this plant remains a vital subject of interest in the search for natural bioactive agents.
- Synonyms
- Uncaria Zeyheri
- Common names
- Not available
- Family
- Pedaliaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Harpagophytum zeyheri is a distinctive plant widely recognized by several different names depending on the region and local dialect. It is most commonly referred to in English as devil's claw or devil's-claw, reflecting its unique physical appearance. Within specific habitats, it is also known as the Bushveld Devilclaw or the Savanna Devilclaw. Furthermore, the plant holds a local identity through the name ekakata. Regardless of which name is used, this species remains a significant botanical subject.
Sources: Catalogue of Life (COL)
Synonyms
Harpagophytum zeyheri is a botanical species that is often discussed in various scientific contexts. Within taxonomic literature, this plant is also recognized by the synonym Uncaria zeyheri. Understanding these overlapping names is crucial for researchers tracking the plant's medicinal properties. Such nomenclature shifts can sometimes lead to confusion when navigating botanical databases. Therefore, recognizing both identifiers ensures accurate identification and study of this specific organism.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Harpagophytum zeyleri is a remarkable botanical specimen belonging to the kingdom Plantae. This unique species is classified under the class Equisetopsida, marking its place within the broader evolutionary tree. It is further defined by its membership in the order Lamiales, showcasing its specific morphological lineage. Within this order, the plant resides in the Pedaliaceae family, which helps scientists understand its biological connections. Ultimately, its identity is solidified by its classification within the genus Harpagophytum.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Lamiales |
| Family | Pedaliaceae |
| Genus | Harpagophytum |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Harpagophytum zeyheri is a resilient plant primarily distributed across the diverse landscapes of South Tropical Africa. Its natural range extends through the vast terrains of Angola, Mozambique, Zambia, and Zimbabwe. Additionally, the species can be found thriving within the Southern African region of Botswana. This widespread geographic presence highlights the plant's ability to adapt to various ecological niches throughout the continent. Consequently, understanding its distribution is essential for studying the botanical richness of these African territories.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Harpagophytum zeyheri is a distinctive herb characterized by its self-supporting growth form. This plant typically maintains a modest stature within its natural habitat. Its height generally ranges from a minimum of 0.5 meters to a maximum of 1 meter. These physical dimensions define its structural presence in the ecosystem.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Harpagophytum zeyheri is a significant medicinal plant known for its notable therapeutic potential. Research indicates that this species possesses distinct analgesic properties that can help alleviate pain. In addition to its pain-relieving effects, the plant also exhibits strong anti-inflammatory activities. These biological benefits are largely attributed to its specific iridoid content, including the presence of harpagoside. Consequently, the species is considered a reliable and valuable source for the production of Harpagophyti radix.
Compounds
Harpagophytum zeyheri is a medicinal plant known for its complex chemical composition, specifically its rich profile of iridoids. Within this plant, harpagoside serves as a primary constituent that contributes to its therapeutic properties. Additionally, the species is uniquely characterized by the presence of 8-p-Coumaroylharpagide. This specific compound is a representative iridoid found only in Harpagophytum zeyheri, distinguishing it from related species. By analyzing the ratio of these specific iridoids, researchers can accurately identify and distinguish the plant's chemical signature.
Conditions
Harpagophytum zeyheri is utilized in phytomedicines to treat various inflammation-related disorders. Research indicates that this plant species has the capacity to treat respiratory burst by suppressing the production of reactive oxygen species. It has also demonstrated the ability to treat challenges involving opsonised Staphylococcus aureus. Additionally, the plant can treat responses induced by phorbol myristate acetate (PMA) through its anti-inflammatory effects. Finally, its medicinal properties are noted for their ability to treat Fusobacterium nucleatum.
Preparations
Harpagophytum zeyheri is prepared as Harpagophyti radix to be used as a medicinal source. This specific plant species is also processed into aqueous extracts for various applications. These aqueous extracts are often part of commercial dried mixtures containing different species. Both the prepared radix and the extracts demonstrate significant therapeutic potential. Consequently, the plant serves as a key component in these specific medicinal preparations.